Picture

Questions?

+1-866-353-3335

SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: BCC Research | PRODUCT CODE: 1239685

Cover Image

PUBLISHER: BCC Research | PRODUCT CODE: 1239685

Global Market for Stem Cells

PUBLISHED:
PAGES: 139 Pages
DELIVERY TIME: 1-2 business days
SELECT AN OPTION
PDF & Excel (Single User License)
USD 5500
PDF & Excel (2-5 Users)
USD 6600
PDF & Excel (Site License)
USD 7920
PDF & Excel (Enterprise License)
USD 9504

Add to Cart

Highlights:

The global stem cell market reached $32.1 billion in 2022 and should reach $65.6 billion by 2027, with a compound annual growth rate (CAGR) of 15.3% during the forecast period of 2022-2027.

North American stem cell market reached $13.5 billion in 2022 and should reach $28.6 billion by 2027, with a CAGR of 16.2% during the forecast period of 2022-2027.

Asia-Pacific stem cell market reached $6.9 billion in 2022 and should reach $15.8 billion by 2027, with a CAGR of 17.8% during the forecast period of 2022-2027.

Report Scope:

This report discusses the implications of stem cell research and commercial trends in the context of the current size and growth of the pharmaceutical market, both in global terms and analyzed by the most important national markets. The important technologies supporting stem cells are reviewed, and the nature and structure of the stem cell industry is discussed, with profiles of the leading companies, including recent merger and acquisition (M&A) activity. Five-year sales forecasts are provided for the national markets and the major therapeutic categories of the products involved.

Report Includes:

  • 18 data tables and 14 additional tables
  • An up-to-date overview and analysis of the global markets for (biological) stem cells and related products
  • Analyses of the global market trends, with historic revenue data for 2021, estimates for 2022 and 2023, and projections of compound annual growth rates (CAGRs) through 2027
  • Estimation of the actual market size and revenue forecast for global stem cells market in USD million terms, and corresponding market share analysis by product, application, end user, and region
  • Highlights of emerging technology trends, market opportunities and deterrents estimating current and future demand of stem cells related products and their derivatives for drug discovery
  • Discussion of market dynamics that impact the growth of the market for biological stem cells, clinical applications, market regulations, industry structure, and penetration of technologies within the biotech industry
  • Review of the patents and patent applications on stem cell research, and corresponding research/scientific publications during the analysis period
  • Competitive landscape of the key manufacturers and suppliers of the stem cell-related drug market, their product portfolios, financial updates, and major growth strategies within the marketplace
  • Company profiles of major players within the industry, including 3-D Matrix Medical Technology, International Stem Cell Corp., ReNeuron Group, and U.S. Stem Cell Inc.
Product Code: BIO035H

Table of Contents

Chapter 1 Introduction

  • 1.1 Study Goals and Objectives
  • 1.2 Reasons for Doing the Study
  • 1.3 What's New in This Update?
  • 1.4 Scope of Report
  • 1.5 Market Analyses and Forecasts
  • 1.6 Methodology
  • 1.7 Intended Audience
  • 1.8 Information Sources
  • 1.9 Analyst's Credentials
  • 1.10 BCC Custom Research
  • 1.11 Related BCC Research Reports

Chapter 2 Summary and Highlights

  • 2.1 Definitions
  • 2.2 Applications
  • 2.3 Research and Commercialization
  • 2.4 Funding
  • 2.5 Market

Chapter 3 Overview

  • 3.1 Cells
  • 3.2 Stem Cells
    • 3.2.1 Induced Pluripotent Stem Cells

Chapter 4 Stem Cell Research

  • 4.1 History
  • 4.2 Embryonic Stem Cells
    • 4.2.1 Growth and Identification of Embryonic Stem Cells
    • 4.2.2 Stimulating Embryonic Stem Cells to Differentiate
  • 4.3 Adult Stem Cells
    • 4.3.1 Mesenchymal Stem Cells
    • 4.3.2 Hematopoietic Stem Cells
    • 4.3.3 Neural Stem Cell
    • 4.3.4 Endothelial Progenitor Cell
    • 4.3.5 Epithelial Stem Cell
    • 4.3.6 Very Small Embryonic-Like Cell
  • 4.4 Cord Blood Stem Cells
  • 4.5 Induced Pluripotent Stem Cells
    • 4.5.1 Nuclear Reprogramming
  • 4.6 Cell-Based Therapeutics
    • 4.6.1 Embryonic-Derived Stem Cells
    • 4.6.2 Adult and Progenitor-Derived Stem Cells
    • 4.6.3 Engineered Stem Cells for Transplantation
  • 4.7 Therapeutic Stem Cell Banking
  • 4.8 Stem Cell-Based Biomedical Research
  • 4.9 Stem Cell Research Centers
  • 4.10 Regulation of Stem Cell Research
    • 4.10.1 National Regulatory Measures
  • 4.11 Practicalities of Stem Cell Research and Production
    • 4.11.1 Stem Cell Production
    • 4.11.2 Stem Cell Acquisition
    • 4.11.3 Stem Cell Production Economics
    • 4.11.4 Customized Therapy
    • 4.11.5 Banks
    • 4.11.6 Novel Stem Cell Production Developments
    • 4.11.7 Isolation and Engineering
    • 4.11.8 Adult Stem Cells
    • 4.11.9 Embryonic Stem Cells
    • 4.11.10 Induced Pluripotent Stem Cells
    • 4.11.11 Bioprinting
  • 4.12 Stem Cell Banking
  • 4.13 Impact of COVID-19 on Stem Cell Therapy
    • 4.13.1 Impact of COVID-19 on iPSCs

Chapter 5 Stem Cell Applications

  • 5.1 Regenerative Medicine
  • 5.2 Current Stem Cell Therapy Applications
    • 5.2.1 Cancer

Chapter 6 Stem Cell Patents

  • 6.1 General Background on Patents
    • 6.1.1 Stem Cell Patents
  • 6.2 Policies by Country
    • 6.2.1 United States
    • 6.2.2 Canada
    • 6.2.3 European Patent Convention
    • 6.2.4 United Kingdom
    • 6.2.5 Germany
    • 6.2.6 Japan
    • 6.2.7 China
  • 4.3 Induced Pluripotent Stem Cells
  • 4.4 Recent Patent Activity
  • 4.5 Clinical Trials

Chapter 7 Stem Cell Markets

  • 7.1 Markets for Stem Cells
  • 7.2 Market Dynamics
    • 7.2.1 Market Drivers
    • 7.2.2 Market Opportunities by Therapeutic Class
  • 7.3 Global Market Estimates and Forecasts
    • 7.3.1 North America
    • 7.3.2 Europe
    • 7.3.3 Asia-Pacific
    • 7.3.4 Rest of the World

Chapter 8 Emerging Technologies in the Market

  • 8.1 Stem Cell Market in 2022 and Beyond
    • 8.1.1 Oncology Applications
    • 8.1.2 Dermatology Applications
    • 8.1.3 Genetically Modified Stem Cells
    • 8.1.4 Disease Modeling
    • 8.1.5 Sustainable Meat Sources
    • 8.1.6 Bioprinting
    • 8.1.7 Surgery
    • 8.1.8 COVID-19
  • 8.2 Emerging Technologies in Stem Cell Research

Chapter 9 Company Profiles

  • 3-D MATRIX MEDICAL TECHNOLOGY
  • ATHERSYS INC.
  • BEIKE BIOTECHNOLOGY CO. LTD.
  • BRAINSTORM CELL THERAPEUTICS INC.
  • CELYAD
  • CYTORI THERAPEUTICS INC.
  • EPISTEM LTD.
  • FUJIFILM CELLULAR DYNAMICS INC. (FCDI)
  • GAMIDA CELL LTD.
  • HYBRID ORGAN GMBH
  • INTERNATIONAL STEM CELL CORP.
  • ARTERIOCYTE MEDICAL SYSTEMS INC. (ISTO BIOLOGICS)
  • LISATA THERAPEUTICS.
  • MESOBLAST LTD.
  • RENEURON GROUP
  • STEMEDICA CELL TECHNOLOGIES INC.
  • STEMINA BIOMARKER DISCOVERY INC.
  • STEMPEUTICS
  • U.S. STEM CELL INC.
  • VERICEL CORP.
  • VERASTEM INC.
  • VIACYTE INC.
  • VITRO BIOPHARMA
  • WICELL RESEARCH INSTITUTE

Chapter 10 Appendix: Glossary

Product Code: BIO035H

List of Tables

  • Summary Table : Global Stem Cell Market, by Region, Through 2027
  • Table 1 : Funding for Various Research, 2016-2023 (Estimated)
  • Table 2 : Bioprinting Emerging Platforms
  • Table 3 : Countries Engaged in the ISCBI Program
  • Table 4 : Patents Related to Induced Pluripotent Stem-Cells, 2021 and 2022
  • Table 5 : Stem Cell Patents, by Type, 2021
  • Table 6 : Select Clinical Trials on Stem Cell Research in 2021
  • Table 7 : Select Clinical Trials on Stem Cell Research in 2022
  • Table 8 : Select Clinical Trials on Stem Cells in January 2023
  • Table 9 : Clinical Trials on Various Heart Conditions, 2021-2022
  • Table 10 : Clinical Trials on Neurodegenerative Diseases, 2021-2022
  • Table 11 : Global Stem Cell Market, by Region, Through 2027
  • Table 12 : North American Stem Cell Market, by Country, Through 2027
  • Table 13 : U.S. Stem Cell Market, Through 2027
  • Table 14 : Canadian Stem Cell Market, Through 2027
  • Table 15 : Mexican Stem Cell Market, Through 2027
  • Table 16 : Regulatory Scenario of European Country
  • Table 17 : European Stem Cell Market, by Country, Through 2027
  • Table 18 : French Stem Cell Market, Through 2027
  • Table 19 : German Stem Cell Market, Through 2027
  • Table 20 : Italian Stem Cell Market, Through 2027
  • Table 21 : Spanish Stem Cell Market, Through 2027
  • Table 22 : U.K. Stem Cell Market, Through 2027
  • Table 23 : Asia-Pacific Stem Cell Policies, 2021
  • Table 24 : Asia-Pacific Stem Cell Market, by Country, Through 2027
  • Table 25 : List of Approved Human Somatic Cell-Processed Products in Japan
  • Table 26 : Japanese Stem Cell Market, Through 2027
  • Table 27 : Chinese Stem Cell Market, Through 2027
  • Table 28 : List of Approved Stem Cell Therapies and Clinical Trials on Stem Cell Therapies for Diseases in India
  • Table 29 : Cost of Stem Cell Therapy in India, U.K. and U.S.
  • Table 30 : Indian Stem Cell Market, Through 2027
  • Table 31 : Rest of the World Stem Cell Market, Through 2027

List of Figures

  • Summary Figure : Global Stem Cell Market, by Region, 2020-2027
  • Figure 1 : Early Development of Embryo
  • Figure 2 : Funding for Stem Cell Research, 2016-2023 (Estimated)
  • Figure 3 : Stem Cell Therapy Application in Cancer Treatment
  • Figure 4 : Distribution of Clinical Trial Phases on Stem Cell Therapy, 2023
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!